CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Principal Accounting Officer acquired 2,857 shares (grant or award)
- 4 Grant or award President & CMO acquired 2,660 shares (grant or award)
- 4 Grant or award CEO acquired 5,000 shares (grant or award)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 2,250 shares (to pay taxes)
- 4 Shares withheld for taxes President & CMO gave up 3,957 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 10,125 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 6,088 shares (to pay taxes)
- 4 Open-market buy Executive Chairman bought 10,000 shares at $4.59 ($45,850)
- 4 Open-market buy CEO bought 10,000 shares at $4.59 ($45,850)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 24 · 465 filings